Rounded shape Rounded shape
History of Neogen

History of Neogen

2007

  • Creation of Neogen N.V. by Eric Dubois and Khaled Dandachi with developments of injectable products:
  1. Paracetamol IV,
  2. Pantoprazole IV,
  3. Zoledronic acid IV,
  4. Teicoplanine IV,
  5. Fluconazole IV.

2008

  • First submission of Pantoprazole IV.

2009

  • Submission of Paracetamol IV, Zoledronic acid 4mg/5ml.
  • MA for Pantoprazole IV.

2010

  • Creation of Alter Pharma to support new ventures in developments of other forms.
  • DCP approval for Paracetamol IV in 20 countries.

2011

  • Move to Anderlecht, Brussels office.
  • Launch of Paracetamol IV in different countries.

2012

  • Expansion to many different countries, first PIV submission in the US.
  • Opening of Stamullen, Dublin office.

2013

  • Launch of the first oral product: Paracetamol tabs.

2014

  • Founding of Generic Pharma International Limited.

2015

  • First marketing authorization granted in the USA.

2016

  • Incorporation of Milla Pharmaceutical Limited in the USA.
  • First own submission in the USA.
‹ Back